Drug reactions may mimic several dermatoses, including lupus erythematosus. We present an 80 year old female patient on multiple medications, who presented with blisters on her hands and arms for two weeks, which then generalized to the rest of her body. The patient was evaluated by a dermatologist, and biopsies for hematoxylin and eosin (H&E) examination, as well as for direct immunofluorescence (DIF) and immunohistochemistry (IHC) were performed. The H&E biopsy examination revealed a mild, superficial, perivascular dermal infiltrate of lymphocytes, histiocytes and abundant eosinophils; neutrophils were rare. No vasculitis was noted. DIF revealed positive basement membrane (BMZ) staining, primarily with patchy Complement/C3c and fibrinogen; in addition, strong reactivity to dermal blood vessel was appreciated. Antibodies to cell junction-like structures were also noted in the epidermis and dermis with these two antibodies. IHC using similar immunoglobulins and complement components showed similar patterns. We observed that contrary to lupus erythematosus, neither IgG nor IgM were positive at the BMZ.
Introduction
Drug-induced lupus erythematosus (DIL) is an autoimmune disorder, caused by chronic use of selected medications. These drugs cause an autoimmune response that can produce a clinical presentation similar to those of systemic lupus erythematosus (SLE). There are multiple known medications that elicit DIL, but three are most strongly associated: hydralazine, procainamide, and isoniazid [1] [2] [3] .
Case Report
We present an 80 year old female patient, who was using multiple medications and presented blisters on her hands and arms for two weeks. With the rash, the patient described flulike symptoms. The patient also had a history of chronic leg lymphedema. Physical exam displayed erythematous papules and wheals, with no hyperpigmentation or atrophy. The patient was taking oral simvastatin, aspirin 81 mgs/day, lisinopril, Januvia®, Nexium®, hydralazine, Tylenol, and metropolol tartrate. On physical exam, the lesions were present on the bilateral forearms, hands and wrists, and focally on the face and legs. Skin biopsies for hematoxylin and eosin (H&E) examination, as well as for direct immunofluorescence (DIF) and immunohistochemistry (IHC) were performed and processed as previously described [4] [5] [6] [7] .
Microscopic examination:
Examination of the H&E tissue sections demonstrated a histologically unremarkable epidermis. No subepidermal blistering was noted. Within the dermis, a mild, superficial, perivascular infiltrate of lymphocytes, histiocytes and abundant eosinophils was identified. Neutrophils were rare (Fig. 1 ).
Direct immunofluorescence (DIF):
DIF was performed, and revealed the following results: IgE (+, focal superficial dermal perivascular); Complement/C1q (-); complement/C3c (+++, shaggy in patches at the basement membrane zone (BMZ), in the dermal blood vessels and directed against some types of cell junctions in the epidermis and the dermis); Complement/C4(+, focal dermal cell junctions); and fibrinogen(patterns and positivity similar to C3c) (Fig. 1). www.odermatol.com 
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Fibrinogen and kappa light chain antibodies stained focal subcorneal areas. Epidermal cytoid bodies were observed, and demonstrated positive staining with IgM, fibrinogen, kappa light chains and complement/C3c. Antibodies to Ro/SSA-were positive, predominately with Complement/C3c. Anti-keratin antibodies were seen in the epidermis with IgM (Fig. 2) . Immunostochemistry staining revealed similar findings to those seen by DIF, and also reactivity to dermal blood vessels with IgA ( Fig. 1) . DIF, demonstrating positive staining at the basement membrane zone with FITC conjugated C3c (yellow/green staining; red arrow). Epidermal keratinocyte nuclei were counterstained with Dapi (blue), and the upper layers of the epidermis were stained with rhodamine conjugated Ulex europaeus agglutinin(pink/red staining).
Discussion
Our patient was taking many medications that have been associated with DIL, and thus this diagnosis was favored given our pathologic findings. Clinically, DIL patients often report flu-like and joint discomfort symptoms. Our patient reported a chronic osteoarthalgia, and we could not determine if our DIL diagnosis contributed to this clinical problem. Additional signs and symptoms of DIL include myalgia, fatigue, pericarditis and/ or pleuritis; in addition, positive anti-histone antibodies are noted in 95% of cases [1] [2] [3] . Our patient was negative for antihistone antibodies, but positive for antibodies against SS-A/Ro with Complement/C3c. In DIL, the lesions classically recede after discontinuing use of the eliciting drugs [1] [2] [3] . For therapy of our patient, Tacrolimus® 1% cream was prescribed 3 times a day topically, as well as triamcinolone acetonide 0.1% topical cream. In recalcitrant cases of DIL, it may be also necessary to add systemic corticosteroids and/other immunosuppressive agents [3] . Similar to expected findings in lupus erythematosus, we observed cytoid bodies with IgM antibodies. In addition, in our case we noted cytoid body antibodies with Complement/C3c, fibrinogen and subcorneal antibodies that are not classically described in lupus. We observed tissue fixed deposits of immunoglobulin M present in the cytoplasm of epidermal keratynocytes; however, instead of the 3 reported patters described in normal skin [8, 9] , our reactivity was present throughout the entire epidermis. Also remarkable was the reactivity to some type(s) of likely cell junctions in the epidermis and dermis, best appreciated with anti-Complment/C3c and fibrinogen. In conclusion, we note differences with classic lupus erythematosus in our case, including lack of an H&E interface dermatitis and the H&E presence of dermal eosinophils. Our case also features immunopathological features that differ from lupus; we noted positive antibodies to Ro/SSA, but with Complement/C3c. Further, in DIF and IHC our case differs from classic lupus due to a lack of linear deposits of IgG or IgM at the basement membrane zone, instead, patchy Complement/ C3c and fibrinogen were observed. We also observed significant reactivity to dermal blood vessels, but no vasculitis as noted in selected classic cases of lupus. We also observed reactivity to several likely cell junctions in epidermis and dermis, whose nature remains unknown. Further studies utilizing sera against epidermal and dermal antigens may be helpful in characterizing these putative epitopes. which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
